FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
FSTX
Delisted
FSTX was delisted on the 8th of March, 2023.
59 hedge funds and large institutions have $57.8M invested in F-star Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
47% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 19
93% less call options, than puts
Call options by funds: $331K | Put options by funds: $4.8M
Holders
59
Holding in Top 10
2
Calls
$331K
Puts
$4.8M
Top Buyers
| 1 | +$6.32M | |
| 2 | +$3.46M | |
| 3 | +$1.14M | |
| 4 |
VAM
Vazirani Asset Management
New York
|
+$790K |
| 5 |
BCM
BCK Capital Management
Stamford,
Connecticut
|
+$540K |
Top Sellers
| 1 | -$1.21M | |
| 2 | -$845K | |
| 3 | -$760K | |
| 4 |
HF
HRT Financial
New York
|
-$558K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$370K |